Symbolbild · KI-generiert
QScreen AI Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
QScreen AI Inc. is an artificial intelligence ("AI") company developing disruptive and cutting-edge tools for impairment testing and healthcare testing. The Issuer's proprietary technology uses facial and voice recognition to identify both cannabis and alcohol impairment by utilizing multiple features along with numerous different data points. The Issuer is also developing cutting edge screening technologies for the healthcare industry. QScreen AI Inc. is expanding its proprietary AI technology to screen for infectious diseases, and also to screen for psychiatric and/or brain disorders such as depression, dementia and Alzheimer’s disease.
Company description as published by the issuer via Canadian Securities Exchange.
Comparable companies
Companies in the Artificial Intelligence & Software sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| QScreen AI Inc. | QAI | CSE | 5 Mio. USD |
| JasperX Technologies Inc. | JSPX | TSXV | 5 Mio. USD |
| Encore Technologies Corp. | ENCR | CSE | 5 Mio. USD |
| SureNano Science Ltd | SURE | CSE | 5 Mio. USD |
| Mobio Technologies Inc. | MBO | TSXV | 5 Mio. USD |
| Sabio Holdings Inc. | SBIO | TSXV | 5 Mio. USD |
| Clara Technologies Corp. | CLTE | CSE | 5 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.